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BACKGROUND: The body composition in overweight and obese hemodialyzed patients (HD) remains ill-defined. This study
evaluates in HD patients the influence of body size, as indicated by body mass index (BMI, kg=m2), on body composition by
measuring bioimpedance analysis (BIA)-derived variables (phase angle (PA), fat-free mass (FFM) and body cell mass (BCM).
METHODS: We studied 50 Caucasian patients (mean age 62.89.2 y) on standard bicarbonate hemodialysis for at least
12 months who regularly achieved dry weight in post-HD, received similar dialysis doses and were free from inflammation=infec-
tion. Thirty-eight gender- and age-matched healthy subjects were included as controls (CON). Both HD and CON were divided
into three groups on the basis of their BMI(kg=m2) 18.5 – 24.9, normal-weight (NW); 25 – 29.9, overweight (OW); and 30,
obese (OB). In HD patients, BIA was performed 30 min after the end of dialysis.
RESULTS: Seven patients were obese (12%) while 16 were overweight (32%); in CON, 12 were obese (31%) and 12 overweight
(31%). BIA-measured extracellular water was comparable in all groups. PA, which was similar in normal-weight HD and CON
(6.20.9 and 6.30.8), decreased in OW- and OB-HD patients (5.31.0 and 5.20.6, respectively; P<0.05 vs NW-HD)
while it was unchanged in OW- and OB-CON (6.10.8 and 5.90.5, P<0.05 vs respective HD groups). In OW and OB
patients, the lower PA values were coupled with a major reduction of BIA-derived percentage BCM and FFM (P<0.05 vs NW-
HD, and vs OW- and OB-CON). In patients, PA and BCM correlated with anthropometry-measured FFM. Of note, serum
albumin and protein catabolic rate were significantly reduced in OB patients.
CONCLUSION: In overweight and obese HD patients, BIA-derived FFM, BCM and PA are significantly lower with respect to
normal-weight patients and BMI-matched controls. These abnormalities of body composition are coupled with reduction of
anthropometric measures of lean mass and a decrease of protein intake that, however, becomes significant only in the obese. We
therefore suggest that overweight and obese HD patients are at risk of protein malnutrition in spite of excessive energy intake.
BIA may be considered as a useful diagnostic tool to detect such a condition early.
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Introduction
In uremic patients undergoing maintenance hemodialysis
(HD), protein-energy malnutrition is a frequent clinical
feature, with the prevalence of this phenomenon averaging
20 – 40%.1,2 The presence of protein-energy malnutrition
is a powerful risk factor for morbidity and mortality in
these patients.1,24 – 6 Therefore, the periodic assessment of
nutritional status in dialysis patients is now considered
mandatory.
While several studies have evaluated the body composi-
tion in the entire hemodialysis population,2 no data are
available in the subgroup of overweight patients. However,
this issue is critical and must be addressed; indeed, great
interest has recently focused on the overweight patients,
which account for almost 40% of the hemodialysis popula-
tion.7 The previous studies have focused on the influence of
the overweight status on survival; surprisingly, in spite of the
major risk of death associated with excess weight in the
healthy population,8 a survival advantage of being over-
weight has been reported in HD patients.7,9 In contrast,
other authors have demonstrated that the risk of mortality
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and hospitalization increases with the increment of the
value of body mass index (BMI, kg=m2) when longer periods
of follow-up are considered.10 Acquisition of information on
the nutritional status in overweight=obese HD patients may
provide important insights into the relationship between the
overweight status and the outcome in uremia.
In dialysis, mild to moderate malnutrition is not revealed
by abnormalities of the common nutritional markers that
become manifest only in the advanced stage of disease;6,11,12
consequently, practical and sensible indicators of body com-
position are needed for clinical purposes. Most of the avail-
able methods for evaluating body composition, even though
accurate, cannot easily be used in the clinical setting. Indeed,
anthropometry that adequately assesses the nutritional
status in dialysis13 is not practical to perform on a routine
basis.
Bioelectrical impedance analysis (BIA) is a new and simple
indirect technique that analyzes the body composition by
evaluating some electrical characteristics of the human body
through the application of a low-amplitude alternating elec-
trical current in the body.14,15 BIA evaluates the impedance
of the tissues to the electrical current by measuring the
resistance (R), which is the pure opposition of the tissue to
the flow of electrons, and the reactance (Xc), which reflects
the capacitance of cell membranes and tissues interfaces. A
further BIA variable of interest is the phase angle (PA) — the
angular transformation of the Xc=R ratio
16 — which has been
related to the extent of lean body mass.17 – 19 BIA can be
considered as an excellent alternative to the measurement of
skinfold thickness since BIA variables correlate with anthro-
pometric data.20 Furthermore, this technique allows an early
detection of abnormal nutritional status in physiological
conditions as well as in a variety of pathological conditions,
including uremia.21 – 26 In particular, the alterations of
PA, which is an independent predictor of death in
uremic patients,25,27,28 precede the changes of biochemical
nutritional parameters.25
The current study was designed to gain insights into the
influence of body size, as indicated by body mass index,
upon body composition in hemodialysis patients. To this
aim, we performed bioimpedance analysis and anthropom-
etry in groups of patients with different BMI. Since BIA
primarily measures body water content and assumes a con-
stant hydration factor to predict lean body mass, we enrolled
into the study only patients regularly achieving the
prescribed dry weight.
Methods
Subjects
This investigation includes 50 patients (HD), 24 males and
26 females, with mean age 62.89.2 y and BMI (kg=m2)
within the 18.5 – 35 range, kept on maintenance hemo-
dialysis for at least 1 y. Thirty-eight age- and BMI-matched
healthy subjects constituted the control group (CON, 17
male and 21 female, mean age: 63.36.1 y). All the subjects
gave their informed consent to the study, which was
approved by the Ethical Committee of the Medical School
of the University Federico II of Naples. Both patients and
controls were divided into three groups according to the
value of BMI:29 18.5 – 24.9 (normal-weight, NW); 25 – 29.9
(overweight, OW); 30 (obese, OB). All the study subjects
were allowed ad libitum intake of energy and protein.
We selected hemodialysis patients with stable clinical
conditions according to the following inclusion criteria:
adult; anuric; absence of cancer, infection or any acute
illness in the last 3 months; constancy in the last 3 months
of dialysis dose and modality, dietary intakes, body weight
and routine laboratory measurements. To exclude major
alterations of hydration status, the optimal dry weight was
accurately achieved in each patient according to clinical
criteria: lowest weight at the end of HD session that the
patient can tolerate without intradialysis symptoms (dizzi-
ness, cramps) and hypotension; absence of peripheral or
pulmonary edema; and presence of normal blood pressure
values during the interdialysis period in the absence of
antihypertensive treatment.30 Patients were studied after
the mid-week hemodialysis session to further minimize any
distortion in BIA measures caused by excess tissue fluid.
Patients were dialyzed in the supine position, with the
vascular access being native arteriovenous fistula in all of
them, for 240 min three times per week using cellulose
membranes with surface area of 1.1 – 1.5 m2. Blood and
dialysate flow rates were 250 – 300 and 500 ml=min, respec-
tively. The dialysis solution was bicarbonate-buffered, iso-
tonic, with the temperature constantly kept around 37C.
Body composition
The same investigators performed BIA and anthropometry
measurements in all subjects. In patients the body composi-
tion measurements were obtained 30 min after the end of the
hemodialysis session in order to allow a complete fluid re-
equilibrium.
BIA. Single-frequency BIA was determined at 50 kHz and
800mA with an impedance plethysmograph (model BIA 101
RJL, Akern, Firenze, Italy) according to the standard tetra-
polar technique; to avoid artifacts, the electrodes were placed
on feet, ankles, hands and wrists on the side of the body free
from the vascular access.31,32 Furthermore, to avoid the
influence of fluid redistribution related to postural changes
on BIA measures,33 patients were studied while maintaining
the supine position also after the end of HD session, and
controls after lying in bed for at least 30 min.
The body composition measures were calculated from BIA
(resistance and reactance) and anthropometric (body height
and weight) variables, by using the software provided by
the BIA machine (Akern=RJL Systems) as previously
described.18,34 This predictive model allows total body
water (TBW), body fat mass (BIA-FM) and fat-free mass
Bioimpedance in hemodialysis
B Guida et al
266
International Journal of Obesity
(BIA-FFM), body cell mass (BCM), and extra- and intra-
cellular water (ECW, ICW) to be calculated.
Anthropometry. Anthropometric measurements included
body weight (BW), height and skinfold thickness (ST). Body
mass index (BMI), which is considered a reliable parameter
to estimate obesity as risk factor,35 was calculated as the ratio
body weight=height2 (in kg=m2).29 Skinfold thickness was
determined by Holtain – Tanner – Whitehouse calipers at the
biceps, triceps, subscapular and suprailiac side, according
to Loman, Roche and Martorell and the FFM (A-FFM) was
calculated from the sum of these four skinfolds.36
Biochemical and dialysis data
In patients, blood samples were drawn before the dialysis
session to measure leucocyte number, hematocrit (Ht), and
the plasma levels of urea (reported as blood urea nitrogen,
BUN), albumin, a2 globulin, C reactive protein, creatinine
and cholesterol. A sample was also obtained immediately
after the end of HD session to measure the BUN value. The
Kt=V which is a measure of dialysis dose, was calculated by
the following equation:37 ÿln(Rÿ0.008Td) (4ÿ3.5R) UF=
W, where RBUN post-HD=BUN pre-HD, TdHD time
(hours), UFultrafiltration volume, Wbody weight at
end of dialysis session (kg); Kt=V is a dimensionless measure
of dialysis dose, where K is the urea dialysate clearance
(expressed in ml=ml), t is treatment time (in minutes) and
V is the body volume cleared by urea at a rate K (V approxi-
mately equals total body water, that is, 58% of dry weight).
The protein intake was calculated as protein catabolic rate
(PCR; g=kg ideal body weight=day), by means of the standard
formula, 2.03 DC0.16, where DC is the change in BUN
during dialysis (DCC0ÿCt, where C0predialysis BUN and
Ctpostdialysis BUN, mg=ml) that in steady-state is equal to
the interdialysis rise in BUN. This equation is based on the
assumption that C0 is constant if both urea generation (DC)
and dose of dialysis (Kt=V) remain constant.38
Statistics
Values are given as mean s.d. Differences between patients
and controls were tested by two-tailed Student’s t-test for
unpaired data. Analysis of variance and Bonferroni post-hoc
test were used for the comparison among the three different
BMI group. A P<0.05 was considered significant.
Results
By grouping the study subjects on the basis of the BMI value,
we found that seven HD patients were obese (12%), while 16
were overweight (32%); in CON, the respective values were
31% and 31%.
Table 1 shows the anthropometric and bioelectrical data.
The values of body weight and BMI were comparable in the
three BMI categories, both in patients and in age- and
gender-matched controls; also ECW% was similar in HD
and CON, confirming the absence of over- or dehydration
state in patients.
Body composition data are reported in Table 1. In con-
trols, BIA-measured FFM% and BCM%, as well as antropo-
metry-measured FFM%, decreased in the obese group in
comparison with the normal weight group (P<0.001). Simi-
larly, in patients FFM-A%, FFM-BIA% and BCM% decreased
Table 1 Individual, anthropometric (A) and bioimpedance analysis (BIA) data in hemodialyzed patients (HD,
n50), and in controls (CON, n38) grouped by the value of body mass index
Normal weight Overweight Obese
HD (n 27) CON (n 14) HD (n 16) CON (n12) HD (n 7) CON (n 12)
Age (y) 57.710.6 63.4 5.5 64.7 9.1 61.87.9 66.29.4 65.8 5.1
Gender (F%) 52 50 50 58 57 58
BW (kg) 59.36.5 57.2 6.0 68.3 9.2{ 71.98.7{ 76.77.9{{ 85.2 9.2{{
BMI (kg=m2) 22.01.7 22.9 1.3 27.1 1.7{ 27.61.2{ 33.94.4{{ 33.3 2.3{{
medians 22.8 23.0 26.1 28.0 33.2 33.5
ECW% 37.45.1 39.7 2.9 38.0 4.9 39.33.5 38.12.0 40.2 2.2
FFM-BIA (kg) 40.96.2 41.2 4.1 41.0 7.3* 49.29.0{ 42.53.0* 54.7 9.0{
FFM-A (kg) 44.46.8 41.0 3.8 45.3 8.6 49.77.3{ 44.55.9* 54.2 7.5{
FFM-BIA % 69.06.9 72.1 3.7 59.0 7.7*{ 68.94.6 56.93.2*{ 64.5 5.2{{
FFM-A% 75.17.4 71.7 2.5 68.9 5.9{ 69.24.3 59.02.7*{{ 63.7 3.2{{
FM-BIA (kg) 18.44.8 15.9 6.8 27.6 7.3*{ 21.86.2{ 31.85.2{ 30.2 4.8{{
FM-A (kg) 14.95.2 16.1 2.8 21.8 1.2{ 21.95.3{ 32.22.1{{ 30.0 4.1{{
FM-BIA% 30.96.9 27.8 3.6 40.3 7.8*{ 31.04.5 43.13.2*{ 35.5 5.2{{
FM-A% 25.17.4 28.2 2.5 31.0 5.9{ 30.84.0 40.92.6*{{ 36.1 3.5{{
BCM-BIA (kg) 20.94.6 21.2 2.9 19.3 3.6* 25.15.2{ 19.61.9* 27.4 4.5{
BCM-BIA% 34.96.3 37.0 3.3 27.0 4.5*{ 35.23.8 26.33.0*{ 32.2 3.2{{
*P< 0.05 vs CON; {P< 0.05 vs normal weight; {P< 0.05 vs overweight.
Abbreviations: BW, body weight; BMI, body mass index; ECW, extra-cellular water; FFM, fat-free mass; FM, fat mass; BCM,
body cell mass.
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as compared to patients with normal BMI, with the differ-
ence being significant not only in the obese but also in the
overweight group. In HD, the decrease of percentage FFM
and BCM was coupled with a major increase of adipose
tissue, as indicated by the higher fractional fat mass (FM),
with respect to CON in both overweight and obese, but not
normal-weight, groups. Furthermore, when BCM was mea-
sured as absolute value, we did not find any significant
difference among the three BMI categories in patients,
while a significant increment of absolute BCM value was
detected in parallel with the increase of body weight in
controls. We found a similar pattern of changes for the
absolute value of FFM measured by both anthropometry
and BIA. When comparing CON and HD groups sorted for
BMI, we did not detect significant differences in BCM and
FFM between normal-weight subgroups; on the contrary,
both parameters were significantly lower in overweight and
obese patients (P<0.01), testifying the major reduction of
lean mass in hemodialyzed patients with higher body size.
Interestingly, we observed a parallel decrease of phase
angle in overweight (P<0.005) and obese (P<0.02) HD
patients, while it did not vary in the three CON groups
(Figure 1).
Table 2 shows dialysis data and biochemical markers of
nutritional status in the three groups of patients with differ-
ent BMI. Dialysis age and Kt=V values were comparable in the
three groups. Serum albumin, blood urea nitrogen (BUN)
and protein catabolic rate (PCR) were significantly reduced
in obese with respect to normal-weight patients; also the
interdialysis weight gain (IDWG), was numerically dimin-
ished at higher BMI. Of note, no significant difference in the
biochemical markers of nutritional status was detected
between normal weight and overweight patients. The pre-
sence of a major inflammatory=infectious state in the three
groups of patients was excluded on the basis of the normal
values of leukocyte count, a2 globulin and C reactive protein
levels.
Table 3 depicts the correlation coefficients obtained by
plotting the BIA data (PA and BCM) with the anthropometric
(BMI and FFM) and biochemical markers of nutritional
status. In HD patients, FFM-A and standard laboratory mar-
kers (creatinine and urea nitrogen) correlated with PA and
BCM, while BMI significantly correlated only with PA. On
the contrary, in controls, FFM-A and BMI correlated with
BCM, whereas no significant correlation with PA was
detected.
Figure 1 Phase angle in hemodialyzed patients (HD) and controls (CON), grouped in normoweight (NW), overweight (OW) and obese (OB). P<0.05
vs NW; *P<0.05 vs CON.
Table 2 Dialysis biochemical and nutritional data in hemodialyzed
patients grouped by the value of body mass index
Normal weight
(n27)
Overweight
(n16)
Obese
(n7)
Kt=V 1.0 0.1 1.10.2 1.10.3
Dialysis age (months) 43 25 3724 3823
Albumin (g=dl) 4.1 0.3 4.00.3 3.60.5*{
Creatinine (mg=dl) 10.2 2.3 9.11.2 10.62.1{
Cholesterol (mg=dl) 190 38 20336 20539
Hematocrit (%) 33.6 3.5 32.82.9 32.43.4
PCR 1.3 0.3 1.10.4 1.00.1*
BUN (mg=dl) 89.1 19.8 77.219.1 70.319.1*
IDWG (% BW) 5.0 1.6 4.71.5 4.01.3
Leucocytes (n=mm2) 5678 1241 61441093 5932998
a2 (g=dl) 0.76 0.06 0.820.03 0.790.05
Crp (mg=ml) 0.28 0.18 0.260.19 0.250.13
*P<0.05 vs normal-weight; {P<0.05 vs overweight.
Abbreviations: PCR, protein catabolic rate; BUN, blood urea nitrogen; IDWG,
inter-dialysis weight gain; a2, serum a2 globulin; Crp, C reactive protein.
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Discussion
In this study, 44% of the 50 selected hemodialysis patients
were overweight or obese, with 12% of such individuals
being obese. The size of the sample is small, nevertheless,
the aim of the study was to examine body composition in
HD patients with a BMI value above the normal range, rather
than to assess the prevalence of the phenomenon.
In recent years, a great effort has been made to find
clinical tools for body composition analysis in HD patients.
Sophisticated techniques, such as neutron activation analy-
sis or total body potassium, are accurate and reliable meth-
ods but are expensive and not available for clinical
purposes;39,40 anthropometric measurements also accurately
reflect nutritional status and body composition in dialy-
sis,13,41 but are time-consuming and not practical to take
on a routine basis. On the other hand, clinical and labora-
tory parameters are easy to collect but imprecise.11,42 The
main biochemical parameters suggestive of protein-energy
malnutrition in dialysis, such as serum albumin, dietary
protein intake (indicated by the protein equivalent of total
nitrogen appearance or PCR) and predialysis serum urea
nitrogen correlate with morbidity or mortality,4,5,11 these
markers, however, must be interpreted with caution and,
more important, alterations of such indexes often become
manifest only late in the course of the deteriorating nutri-
tional status in dialysis, that is, after severe malnutrition is
established.6,11,12
Bioelectrical impedance analysis (BIA) allows a fast and
sensitive bedside assessment of human body composi-
tion.14,21 The tetrapolar bioelectrical impedance analysis
described by Shizgal and Jodin et al refers to a three-compart-
ment model body cell mass (BCM), body fat (FM), and
extracellular mass (ECM).15,21 BIA has been cross-validated
in normals, malnourished subjects and HD patients as
well,14,15,17,21 – 23,43,44 by means of BIA indexes, malnutrition
is characterized by a decreased BCM at expense of increased
ECW, that is, by the rise of the ECW – BCM ratio. In pregnant
women the changes of BIA-derived FFM and FM have been
verified by the isotope dilution technique;45 similarly, in
adolescents with malnutrition due to anorexia, BIA appears
to be better at predicting changes of body composition than
the assessment of weight alone or weight in combination
with height.46 Of note is the association in patients mal-
nourished because of surgery, cancer, sepsis or anorexia of
BCM decline with the reduction of PA value.47 – 51
BIA is an adequate and easily accessible clinical tool
for monitoring nutritional status also in uremic
patients.17,20,24 – 26,52 Specifically, in HD patients BIA-derived
BCM and TBW strictly correlate with DEXA-derived BCM
and D2O dilution-measured TBW.
17 Furthermore, in these
patients, the extent of FFM and FM assessed by BIA is
comparable with the data obtained by measuring skinfolds
thickness.53,54 Interestingly, in dialysis the value of PA also
provides information on body composition; the Xc=R ratio is
in fact inversely related to the ECW=TBW ratio.17
Early work has demonstrated that in HD patients, as in
non-uremic subjects, BIA variables and laboratory markers of
nutritional status significantly correlate.55 The present study
extends these previous finding to the oversize dialytic popu-
lation. We observed a direct correlation between bioimpe-
dance measures and the traditional anthropometric and
laboratory markers of nutritional status. Notably, these
results were obtained in the absence of major alterations of
hydration status, as required by the experimental design and
confirmed by the constancy of ECW%. Thus, it is reasonable
to assume that in hemodialysis patients kept at dry weight,
BIA-derived PA, FFM and BCM are reliable indices of body
composition.
The major finding of the study is that, while in non-
uremic controls the BMI increment is associated with unvar-
ied PA, in HD patients a significant decrease of PA occurs at
higher BMI. The change of PA is not characterized by a linear
pattern, being significantly lower in the overweight state and
not worsened in obese patients. This abnormality is probably
critical; indeed, in patients with pre-dialytic chronic renal
failure, the initial impairment of body composition is
revealed by the decline of phase angle that is associated
with a reduced survival, even if the usual biochemical
markers nutritional status are unvaried.27 Similarly, the
reduction of PA is independently associated with an
increased risk of death also in the HD population.25,28 There-
fore, the decline of PA detected in HD patients with higher
BMI is of clinical relevance since it possibly reveals a condi-
tion of impaired nutritional status and increased risk of
death.
In both overweight and obese HD patients, a significant
reduction of BIA-measured BCM% and FFM% was also
detected. This finding was associated with unchanged BCM
and FFM as absolute values and with a major increase of BIA-
derived FM. On the contrary, in controls both absolute BCM
and FFM values increased at higher BMI. Indeed, in most
obese non-uremic individuals the increment of fat mass is
Table 3 Linear correlation analysis between bioimpedance data and
nutritional variables in hemodialyzed patients (n50) and controls
(n38)
BCM PA
r P r P
Controls
BMI 0.52 0.001 ÿ0.23 0.17
FFM-A 0.80 0.001 ÿ0.08 0.64
Patients
BMI ÿ0.16 0.24 ÿ0.34 < 0.02
Creatinine 0.43 < 0.002 0.53 < 0.0001
Cholesterol ÿ0.32 < 0.05 ÿ0.34 < 0.05
Albumin 0.41 < 0.01 0.51 < 0.001
BUN 0.38 < 0.01 0.37 < 0.01
PCR 0.28 0.09 0.32 < 0.05
FFM-A 0.65 < 0.0001 0.47 < 0.01
Abbreviations: BCM, body cell mass; PA, phase angle; BMI, body mass index;
BUN, blood urea nitrogen; PCR, protein catabolic rate; FFM-A anthropometry-
derived fat-free mass.
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associated with a parallel increase of lean mass, each change
accounting for almost half of the excess weight;56 similarly,
non-uremic individuals show a proportional increment of
FFM and FM during intentional overfeeding.57 The pattern of
body composition changes observed in our patients, how-
ever, is not surprising; indeed, it has been previously demon-
strated that in HD patients, hyperleptinemia, which is
typically found in uremic obese,58 is associated with the
isolated increase of fat body mass.59 Therefore, the observa-
tion of a lower BCM% and FFM% coupled with the increase
of FM suggests that oversize HD patients, at variance with
non-uremic subjects, are affected by a poor preservation of
body composition characterized by a major increase of fat
mass at the expense of reduced lean mass. This hypothesis is
supported by the decline of anthropometry-measured FFM.
Interestingly, in obese, but not overweight, patients a sig-
nificant reduction of serum albumin level was also detected.
The reasons underlying such abnormalities of nutritional
status in overweight HD patients are not readily apparent. In
this study the main causes of impaired nutritional status,
such as age,60 treatment time, dose and modalities of dialy-
sis, inflammatory status13 and time on dialysis,61 were
excluded. On the contrary, we detected a different protein
intake across the three BMI groups. In fact, the values of PCR
and pre-dialysis BUN slightly diminished in overweight
patients and were significantly lower in obese patients. In
addition, we found in these patients a numerical decrement
of the interdialytic weight gain, that is a parameter related
with the nutrient intake and nutritional status in HD.62,63
These data therefore indicate a spontaneous reduction of
protein intake in overweight hemodialysis patients. Since
the nutrient intake correlates with the BIA estimates of BCM
and FFM,51 the reduced protein intake may account, at least
in part, for the impaired nutritional status.
In conclusion, in overweight and obese HD patients, BIA-
derived FFM, BCM and PA are significantly lower with
respect to the values detected in normal-weight patients
and BMI-matched non-uremic controls. These abnormalities
of body composition are coupled with the reduction of
anthropometry measures of lean mass as well as with a
decrease of protein intake which, however, becomes evident
only in the obese. Therefore, overweight and obese HD
patients are at risk of protein malnutrition in spite of exces-
sive energy intake and apparent well-being. BIA may be
considered a diagnostic tool to early detect such a condition.
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Appendix
List of abbreviations
BIA, bioelectrical impedance analysis;
HD, hemodialysis;
R, resistance;
Xc, reactance;
PA, phase angle;
TBW, total body water;
BCM, body cell mass;
FFM, fat free mass;
FM, fat mass;
ECW%, extracellular water as a percentage of total body
water;
BCM%, body cell mass as a percentage of body weight;
FFM%, fat free mass as a percentage of body weight;
FM%, fat mass as a percentage of body weight;
BMI, body mass index.
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